Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Larisa V. Gubareva"'
Autor:
Mira C. Patel, Ha T. Nguyen, Philippe Noriel Q. Pascua, Rongyuan Gao, John Steel, Rebecca J. Kondor, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 7, Pp 1410-1415 (2024)
Since May 2023, a novel combination of neuraminidase mutations, I223V + S247N, has been detected in influenza A(H1N1)pdm09 viruses collected in countries spanning 5 continents, mostly in Europe (67/101). The viruses belong to 2 phylogenetically disti
Externí odkaz:
https://doaj.org/article/9e7ebed5eeff4b359fdc654de6da2cd6
Autor:
Teena Mohan, Ha T. Nguyen, Krista Kniss, Vasiliy P. Mishin, Angiezel A. Merced-Morales, Jennifer Laplante, Kirsten St. George, Patricia Blevins, Anton Chesnokov, Juan A. De La Cruz, Rebecca Kondor, David E. Wentworth, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 7, Pp 1953-1957 (2021)
Four cases of oseltamivir-resistant influenza A(H1N1)pdm09 virus infection were detected among inhabitants of a border detention center in Texas, USA. Hemagglutinin of these viruses belongs to 6B.1A5A-156K subclade, which may enable viral escape from
Externí odkaz:
https://doaj.org/article/c701d0f68a2643d69439b2c796161fca
Autor:
Vasiliy P. Mishin, Mira C. Patel, Anton Chesnokov, Juan De La Cruz, Ha T. Nguyen, Lori Lollis, Erin Hodges, Yunho Jang, John Barnes, Timothy Uyeki, Charles T. Davis, David E. Wentworth, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 10, Pp 1969-1972 (2019)
Baloxavir showed broad-spectrum in vitro replication inhibition of 4 types of influenza viruses (90% effective concentration range 1.2–98.3 nmol/L); susceptibility pattern was influenza A ˃ B ˃ C ˃ D. This drug also inhibited influenza A viruses
Externí odkaz:
https://doaj.org/article/f8fd3e4e7d9b409cad2bcbbe53b4b083
Autor:
Ha T. Nguyen, Tung Nguyen, Vasiliy P. Mishin, Katrina Sleeman, Amanda Balish, Joyce Jones, Adrian Creanga, Henju Marjuki, Timothy M. Uyeki, Dang H. Nguyen, Diep T. Nguyen, Hoa T. Do, Alexander I. Klimov, Charles T. Davis, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 12, Pp 1963-1971 (2013)
We assessed drug susceptibilities of 125 avian influenza A(H5N1) viruses isolated from poultry in Vietnam during 2009–2011. Of 25 clade 1.1 viruses, all possessed a marker of resistance to M2 blockers amantadine and rimantadine; 24 were inhibited b
Externí odkaz:
https://doaj.org/article/02c960cc0676449f80f5883300bf87a0
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 9, Pp 1521-1524 (2013)
Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors,
Externí odkaz:
https://doaj.org/article/93f5b18b81514ca9878bec841a39f8ac
Autor:
Aaron D. Storms, Larisa V. Gubareva, Su Su, John T. Wheeling, Margaret Okomo-Adhiambo, Chao-Yang Pan, Erik Reisdorf, Kirsten St. George, Robert Myers, Jason T. Wotton, Sara Robinson, Brandon Leader, Martha Thompson, Marjorie Shannon, Alexander Klimov, Alicia M. Fry
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 2, Pp 308-311 (2012)
During October 2010–July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009–10 influenza season. Of resistant viruses from 2010–11 and 2009–10, 26% and 89%, respectiv
Externí odkaz:
https://doaj.org/article/4866c9529bd5494a8c841f89a186bfb9
Autor:
Katrina Sleeman, Tiffany G. Sheu, Zack Moore, Susan Kilpatrick, Shikha Garg, Alicia M. Fry, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 11, Pp 2043-2046 (2011)
Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that
Externí odkaz:
https://doaj.org/article/ca155763da454af0947b2e81b59683e0
Autor:
Larisa V. Gubareva, Yan Li, Alexander I. Klimov, Tiffany G. Sheu, James Smagala, Vasiliy P. Mishin, Ha T. Nguyen, Kristina Ballenger, Katrina Sleeman, Margaret Okomo-Adhiambo
Publikováno v:
Viruses, Vol 2, Iss 10, Pp 2269-2289 (2010)
Neuraminidase inhibitors (NAIs) are vital in managing seasonal and pandemic influenza infections. NAI susceptibilities of virus isolates (n = 5540) collected during the 2008–2009 influenza season were assessed in the chemiluminescent neuraminidase
Externí odkaz:
https://doaj.org/article/b1e528a4c5e14b1aa50a7686299536c1
Autor:
Nila J. Dharan, Monica Patton, Alicia M. Siston, Julie Morita, Enrique Ramirez, Teresa R. Wallis, Varough M. Deyde, Larisa V. Gubareva, Alexander I. Klimov, Joseph S. Bresee, Alicia M. Fry
Publikováno v:
Emerging Infectious Diseases, Vol 15, Iss 12, Pp 1973-1976 (2009)
An outbreak of oseltamivir-resistant influenza A (H1N1) occurred in a long-term care facility. Eight (47%) of 17 and 1 (6%) of 16 residents in 2 wards had oseltamivir-resistant influenza A virus (H1N1) infections. Initial outbreak response included t
Externí odkaz:
https://doaj.org/article/a6b40a3ffec346b8b008b550f2fda506
Autor:
Kenneth C. Earhart, Nasr M. Elsayed, Magdi D. Saad, Larisa V. Gubareva, Ahmed Nayel, Varough M. Deyde, Ali Abdelsattar, Ahmad S. Abdelghani, Bruce R. Boynton, Moustafa M. Mansour, Hala M. Essmat, Alexander Klimov, Deidra Shuck-Lee, M.R. Monteville, Jeffrey A. Tjaden
Publikováno v:
Journal of Infection and Public Health, Vol 2, Iss 2, Pp 74-80 (2009)
Summary: In December 2006, three human specimens were received that were suspected positive for influenza A(H5N1). The specimens were tested using real time PCR. And the presence of A(H5N1) virus was confirmed in 2 patients (16F and 26M), The NA sequ
Externí odkaz:
https://doaj.org/article/6e88256a6c654faf8836bb0847187a06